Effects of clonidine on human middle cerebral artery flow velocity and cerebrovascular CO2 response during sevoflurane anesthesia

Journal of Neurosurgical Anesthesiology

Volumn 11, Issue 3, 1999, Pages 173-177

  Maekawa, T ^a   Cho, S ^a   Fukusaki, M ^a   Shibata, O ^a   Sumikawa, K ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Clonidine; CO2 response; Middle cerebral artery flow velocity; Sevoflurane

Indexed keywords

CARBON DIOXIDE; CLONIDINE; SEVOFLURANE;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; CARDIOVASCULAR AUTOREGULATION; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INHALATION ANESTHESIA; INHALATIONAL DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY; ORAL DRUG ADMINISTRATION; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033055249     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008506-199907000-00003     Document Type: Article

References (27)

1. Bonnet F, Boico O, Rostaing S, et al. Clonidine-induced analgesia in postoperative patients: epidural versus intramuscular administration. Anesthesiology 1990;72:423-427.
2. Carabine UA, Wright PMC, Moore J. Preanaesthetic medication with clonidine: a dose-response study. Br J Anaesth 1991;67:79-83.
3. Unnerstall JR, Kopajtic TA, Kuhar MJ. Distribution of alpha2-agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res Rev 1984;319:69-101.
4. Carabine UA, Milligan KR, Moore JA. Adrenergic modulation of preoperative anxiety: a comparison of temazepam, clonidine, and timolol. Anesth Analg 1991;73:633-637.
5. Flacke JW, Bloor BC, Flacke WE, et al. Reduced narcotic requirement by clonidine with improved hemodynamic and adrenergic stability in patients undergoing coronary bypass surgery. Anesthesiology 1987;67:11-19.
6. Bloor BC, Flacke WE. Reduction in halothane anesthetic requirement by clonidine, an alpha-adrenergic agonist. Anesth Analg 1982; 41:741-745.
7. Chadha R, Padmanabhan V, Joseph A, et al. Oral clonidine pretreatment for hemodynamic stability during craniotomy. Anaesth Intensive Care 1992;20:341-344.
8. 2. J Cereb Blood Flow Metab 1986;6:358-365.
9. James IM, Larbi E, Zaimis E. The effect of the acute intravenous administration of clonidine (St 155) on cerebral blood flow in man. Br J Pharmacol 1970;39:198-199.
10. Lee H, Caldwell JE, Dodson B, et al. The effect of clonidine on cerebral blood flow velocity, carbon dioxide cerebral vasoreactivity, and response to increased arterial pressure in human volunteers. Anesthesiology 1997;87:553-558.
11. Zornow MH, Maze M, Dyck JB, et al. Dexmedetomidine decreases cerebral blood flow velocity in humans. J Cereb Blood Flow Metab 1993;13:350-353.
12. Karlsson BR, Forsman M, Roald OK, et al. Effect of dexmedetomidine, a selective and potent α2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth Analg 1990;71:125-129.
13. Fale A, Kirsch JR, McPherson RW. Alpha 2-adrenergic agonist effects on normocapnic and hypercapnic cerebral blood flow in the dog are anesthetic dependent. Anesth Analg 1994;79:892-898.
14. 2-adrenergic agonist dexmedetomidine in the rat. Am J Physiol 1997;272(6 Pt 2):H2547-H2556.
15. Aaslid R. Transcranial Doppler examination techniques. In Aaslid R, ed. Transcranial Doppler Sonography. New York: Springer-Verlag; 1986:56.
16. Cho S, Fujigaki T, Uchiyama Y, et al. Effects of sevoflurane with and without nitrous oxide on human cerebral circulation: transcranial Doppler study. Anesthesiology 1996;85:755-760.
17. Nichols AJ, Ruffolo RR, Jr. Alphal/alpha2 subclassification, alpha-Adrenoreceptors. In Ruffolo RR Jr., ed. Molecular Biology, Biochemistry and Pharmacology. New York: Karger; 1991:1.
18. Toda N. Alpha adrenergic receptor subtypes in human, monkey, and dog cerebral arteries. J Pharmacol Exp Ther 1983;226:861-868.
19. 2-adrenoreceptor agonists and anaesthesia. In: Prys-Roberts C and Brown BR Jr., eds. International Practice of Anaesthesia. Great Britain: The Bath Press; 1996:1/19/1-15.
20. 2 reactivity of cerebral vessels to blood pressure and mean resting blood flow. Neurology 1973;23:21-26.
21. Coughlan MG, Lee JG, Bosnjak ZJ, et al. Direct coronary and cerebral vascular responses in dexmedetomidine. Significance of endogenous nitric oxide synthesis. Anesthesiology 1992;77:998-1006.
22. Elam M, Yao T, Thoren P, et al. Hypercapnia and hypoxia: chemoreceptor-mediated control of locus coeruleus neurons and splanchnic, sympathetic nerves. Brain Res 1981;222:373-381.
23. 2. Brain Res 1986;365:278-288.
24. Gupta S, Heath K, Matta F. Effect of incremental doses of sevoflurane on cerebral pressure autoregulation in humans. Br J Anaesth 1997;79:469-472.
25. Bishop CC, Powell S, Rutt D, et al. Transcranial Doppler measurement of middle cerebral artery blood flow velocity: a validation study. Stroke 1986;17:913-915.
26. Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 1982;57:769-774.
27. Markwalder TM, Grolimund P, Seiler RW, et al. Dependency of blood flow velocity in the middle cerebral artery on end-tidal carbon dioxide partial pressure-A transcranial ultrasound Doppler study. J Cereb Blood Flow Metab 1984;4:368-372.